July 31, 2024
A Pennsylvania federal judge has barred CVS Health Co. from making an interlocutory appeal over his interpretation of regulations in a whistleblower's lawsuit claiming the company's prescription entities falsely reported drug prices to the government. The judge recommended that a trial date be set in the decade-long litigation instead.
April 23, 2020
A Pennsylvania federal judge on Thursday trimmed claims in a whistleblower's False Claims Act suit alleging two CVS Health Co. prescription entities ran a scheme to defraud the government by falsely reporting drug prices subsidized under Medicare Part D, but will let the relator rework her claims.